Thursday, 31 October 2013

U.S. authorities quiz AstraZeneca over Brilinta clinical trial

AstraZeneca is being investigated by U.S. authorities over a major clinical trial that was used to win marketing approval for its new heart drug Brilinta. The British drugmaker said on Thursday it had received a civil investigative demand from th...


more for more more information more info

No comments:

Post a Comment

Note: only a member of this blog may post a comment.